Bethesda, MD, United States of America

Herui Wang

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Lixte Biotechnology, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Herui Wang

Introduction

Herui Wang is a notable inventor based in Bethesda, MD, who has made significant contributions to the field of medical science. His work primarily focuses on developing innovative methods for treating cancer, showcasing his dedication to improving patient outcomes through scientific advancements.

Latest Patents

Herui Wang holds a patent for "Oxabicycloheptanes for modulation of immune response." This invention provides a method of treating subjects afflicted with cancer by administering an effective amount of a PP2A inhibitor. This innovative approach highlights the potential for new therapeutic strategies in oncology.

Career Highlights

Throughout his career, Herui Wang has worked with prominent organizations, including Lixte Biotechnology, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the medical field.

Collaborations

Herui Wang has collaborated with esteemed colleagues such as John S. Kovach and Zhengping Zhuang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Herui Wang's innovative work and dedication to cancer treatment exemplify the impact that inventors can have on healthcare. His contributions continue to inspire future research and development in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…